Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-12-05
1997-11-25
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 5142388, 514428, 514651, 540609, 544106, 546205, 548576, 564347, A61K 31445, C07D21114
Patent
active
056913532
ABSTRACT:
The present invention provides a compound of formula I ##STR1## wherein R.sub.1 is H, OH, halo, OCO(C.sub.1 -C.sub.6 alkyl), OCO(aryl), OSO.sub.2 (C.sub.4 -C.sub.6 alkyl), OCOO(C.sub.1 -C.sub.6 alkyl), OCOO(aryl), OCONH (C.sub.1 -C.sub.6 alkyl), or OCON(C.sub.1 -C.sub.6 alkyl).sub.2 ;
REFERENCES:
patent: 3313853 (1967-04-01), Lednicer
patent: 4133814 (1979-01-01), Jones et a l.
patent: 4380635 (1983-04-01), Peters
patent: 4418068 (1983-11-01), Jones
patent: 4851554 (1989-07-01), Kennedy et al.
patent: 5395842 (1995-03-01), Labrie
patent: 5484796 (1996-01-01), Bryant et al.
Bryant Henry U.
Dodge Jeffrey A.
Boone David E.
Dahlen Garth M.
Eli Lilly and Company
Ivy C. Warren
Janssen Jerry F.
LandOfFree
Method of inhibiting aortal smooth muscle cell proliferation usi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting aortal smooth muscle cell proliferation usi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting aortal smooth muscle cell proliferation usi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2107406